| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1097/QCO.0B013E3282F88B92 |
| P698 | PubMed publication ID | 18448978 |
| P2093 | author name string | Mi-Na Kweon | |
| P433 | issue | 3 | |
| P921 | main subject | vaccine | Q134808 |
| shigellosis | Q327298 | ||
| P304 | page(s) | 313-318 | |
| P577 | publication date | 2008-06-01 | |
| P1433 | published in | Current Opinion in Infectious Diseases | Q15724406 |
| P1476 | title | Shigellosis: the current status of vaccine development | |
| P478 | volume | 21 |
| Q33676706 | A challenge model for Shigella dysenteriae 1 in cynomolgus monkeys (Macaca fascicularis). |
| Q47205506 | A clinically parameterized mathematical model of Shigella immunity to inform vaccine design. |
| Q37668395 | An update on vaccines against Shigella |
| Q34669980 | Applying mathematical tools to accelerate vaccine development: modeling Shigella immune dynamics |
| Q34534027 | Causative species and serotypes of shigellosis in mainland China: systematic review and meta-analysis |
| Q36473218 | Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection |
| Q38586531 | Convergent synthesis of the tetrasaccharide repeating unit of the O-antigen of Shigella boydii type 9. |
| Q85121585 | Defensins play a crucial role in protecting mice against oral Shigella flexneri infection |
| Q40552716 | Development of recombinant vaccine candidate molecule against Shigella infection |
| Q34765669 | Differential response of the cynomolgus macaque gut microbiota to Shigella infection |
| Q37066116 | Establishment of a Shigella sonnei human challenge model in Thailand |
| Q47201110 | Evaluation of Well Designs to Improve Access to Safe and Clean Water in Rural Tanzania. |
| Q42947419 | Facile glycosylation strategy with two-stage activation of allyl glycosyl donors. Application to concise synthesis of Shigella flexneri serotype Y O-antigen |
| Q64059202 | First investigation of the presence of genes in species isolated from children with diarrhea infection in Ahvaz, southwest Iran |
| Q28728768 | High yield production process for Shigella outer membrane particles |
| Q38648043 | In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity. |
| Q37640115 | Inactivated and subunit vaccines to prevent shigellosis |
| Q50039350 | Live non-invasive Shigella dysenteriae 1 strain induces homologous protective immunity in a guinea pig colitis model. |
| Q84938205 | Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice |
| Q42416783 | Mutations in gyrA & parC genes of Shigella flexneri 2a determining the fluoroquinolone resistance |
| Q42946673 | Plasmid-mediated streptomycin and sulfamethoxazole resistance in Shigella flexneri 3a |
| Q34487453 | Prevalence and characterization of human Shigella infections in Henan Province, China, in 2006. |
| Q24628546 | Production of glycoprotein vaccines in Escherichia coli |
| Q46677252 | Protective immunity by oral immunization with heat-killed Shigella strains in a guinea pig colitis model |
| Q40110228 | Rapid Molecular Approach for Simultaneous Detection of Salmonella spp., Shigella spp., and Vibrio cholera |
| Q34375210 | Recent advances in understanding enteric pathogenic Escherichia coli. |
| Q38068954 | Recent progress towards development of a Shigella vaccine |
| Q84592118 | Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine |
| Q33618994 | Shigella flexneri Inhibits Intestinal Inflammation by Modulation of Host Sphingosine-1-Phosphate in Mice |
| Q87419447 | Towards a non-living vaccine against Shigella flexneri: from the inactivation procedure to protection studies |
| Q46431834 | Transcriptional adaptation of Shigella flexneri during adherence to epithelial cells |
| Q33578045 | Vaccines against human diarrheal pathogens: current status and perspectives |
| Q26824128 | Vaccines for low-income countries |
Search more.